Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
471 Leser
Artikel bewerten:
(2)

NNIT A/S: 6/2020 NNIT renews operations maintenance agreement with Novo Nordisk

Company announcement no. 6/2020
Søborg/Copenhagen, March 31, 2020

NNIT renews operations maintenance agreement with Novo Nordisk

NNIT A/S ("NNIT"), a leading provider of IT services and consultancy announces that it has entered into a five-year-agreement with Novo Nordisk, renewing the existing operations maintenance agreement which was to expire at the end of 2020.

The contract covers the infrastructure operations of the global and local application platforms, which Novo Nordisk is relying on in their daily operations. NNIT is delivering full stack platform and infrastructure services up to application level. The contract represents a value of mid triple-digit DKK million amount and takes effect from January 1, 2020.

The new contract secures this important business with Novo Nordisk for another five years. Compared to the previous contract the new contract will reduce NNIT's yearly revenue in this service tower from the Novo Nordisk Group considerably. The decline in revenue in 2020 is as expected and was incorporated into the guidance for 2020 set forth in the company announcement 01/2020.

The COVID-19 situation provides increased uncertainty to the near-term business of NNIT and the potential impact on NNIT is continoulsy monitored and assessed. Currently the guidance for 2020 (organic revenue growth of -4% to -8% in constant currencies, operating profit margin before special items of 6-8% in constant currencies) is maintained, though the COVID-19 situation and the potential changes in customers buying behaviour add uncertainty to the guidance for the year.

Ricco Larsen, Senior Vice President, Life Sciences, NNIT says about the agreement: "We are proud to continuously be able to meet Novo Nordisk's high expectations and extend this agreement matching the market development." He continues: "Our collaboration is continuously maturing and new services such as Hybrid Cloud are added to the stack of platform services we provide today, so that Novo Nordisk remains NNIT's largest customer and we continue to be their strategic partner on IT services."

Contact for further information
Investor relations:
Jens Blüitgen Binger
Head of Investor Relations
Tel: +45 3079 9222
jblb@nnit.com

Press:
Helga Heyn
NNIT Communications
Tel: +45 3077 8080
hhey@nnit.com

About NNIT
NNIT A/S is one of Denmark's leading IT service providers and consultancies. NNIT A/S offers a wide range of IT services and solutions to its clients, primarily in the life sciences sector in Denmark and internationally and to clients in the public, enterprise and finance sectors in Denmark. As of December 31, 2019, NNIT A/S had 3,207 employees. For more information please visit www.nnit.com.

Attachment

  • 06 20200331 Company announcement Novo Nordisk renews operations maintenance agreement with NNIT EN_v1 (https://ml-eu.globenewswire.com/Resource/Download/f6e1fbd3-f664-42ef-bbe6-63376eb53293)
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.